Clinical Trials Logo

Partial Epilepsies clinical trials

View clinical trials related to Partial Epilepsies.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01235403 Completed - Partial Epilepsies Clinical Trials

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

SELF
Start date: June 2010
Phase: Phase 4
Study type: Interventional

To evaluate if a flexible dose escalation of lacosamide, up to the maximum approved dose of 400 mg/day, or to a clinically effective lower dose for an individual patient, improves the tolerability and safety of lacosamide (200 mg to 400 mg/d) as add-on treatment for patients with partial onset epilepsy. Explanation of acronym: SELF = Safety Efficacy Lacosamide Flexibility

NCT ID: NCT00955357 Completed - Partial Epilepsies Clinical Trials

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Start date: August 2009
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.

NCT ID: NCT00655551 Completed - Clinical trials for Partial Onset Seizures

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with partial-onset seizures.

NCT ID: NCT00655486 Completed - Clinical trials for Partial Onset Seizures

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to allow eligible subjects from the parent study, SP925 [NCT00655551] to continue lacosamide and to obtain additional long-term safety data

NCT ID: NCT00552305 Completed - Partial Epilepsies Clinical Trials

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Start date: August 2001
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

NCT ID: NCT00522275 Completed - Partial Epilepsies Clinical Trials

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy